Technology News Covid 19 Moderna Must Fulfil Its Promise To Share Technology To Ensure Covid 19 Vaccine Breakthrough Is Not Limited To Rich Countries Amnesty International

Combo flu and COVID-19 shot shows promise in new Moderna study

Moderna conducted a study to test a combination COVID-19 and flu shot. Researchers tested the shot on 8,000 adults. The pharmaceutical and biotechnology company is targeting 2026 for approval of the ... Read More

FDA clears Moderna’s new COVID vaccine, but with limits

This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. CHICAGO — The Food and Drug Administration has granted ... Read More

Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it

The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company's existing shot, but a second option. The new vaccine, ... Read More

Moderna Provides Update on BLA Submission for Combination Vaccine Against Influenza and COVID-19

CAMBRIDGE, MA / ACCESS Newswire / May 21, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced that in consultation with the U.S. Food and Drug Administration (FDA), the Company has voluntarily ... Read More

FDA approves Moderna’s new lower-dose COVID-19 vaccine

(AP) — The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company’s existing shot, but a second option. The new vaccine, ... Read More

Moderna settles Alnylam patent lawsuits over COVID vaccine technology

Sept 18 (Reuters) - Moderna (MRNA.O), opens new tab has settled related lawsuits that accused it of misusing Alnylam Pharmaceuticals' (ALNY.O), opens new tab patented technology in its COVID-19 ... Read More

COVID-19 mRNA Vaccine Shows Promise in Detecting and Fighting Cancer Tumours

COVID-19 vaccines, which are mRNA-based, may have an unexpected benefit for cancer patients who undergo immunotherapy. According to a new study, these vaccines might boost the effects of immunotherapy ... Read More

FDA grants limited approval to new Covid vaccine from Moderna

Moderna announced this weekend that the Food and Drug Administration approved its lower-dose Covid-19 vaccine for adults 65 and older, as well as people ages 12 to 64 with at least one medical ... Read More

Moderna, Alnylam settle patent row over COVID vaccine delivery technology

Moderna (NASDAQ:MRNA) has agreed to resolve a patent litigation in which Alnylam Pharmaceuticals (NASDAQ:ALNY) has alleged that the delivery technology used in the company’s COVID-19 vaccine has ... Read More

FDA approves Moderna's new lower-dose COVID-19 vaccine

WASHINGTON — The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company’s existing shot, but a second option. The new ... Read More